Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol

被引：0
|
作者：
J. S. Cunha Filho
L. F. Terres
F. Holanda
F. Freitas
C. Glitz
V. K. Genro
E. Arbo
机构：
[1] Universidade Federal do Rio Grande do Sul,Ob/Gyn depto., Hospital de Clínicas de Porto Alegre, Programa de Pós
来源：
Journal of Assisted Reproduction and Genetics | 2007年 / 24卷
关键词：
GnRH antagonists; GnRH agonist; Follicular cohort; Homogenization; Luteal phase oestradiol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：326 / 330
页数：4
相关论文
共 50 条
  • [1] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    Filho, J. S. Cunha
    Terres, L. F.
    Holanda, F.
    Freitas, F.
    Glitz, C.
    Genro, V. K.
    Arbo, E.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (08) : 326 - 330
  • [2] The role of single dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomised study
    Caglar, G. S.
    Isik, A. Z.
    Tuncay, G.
    Akarsu, C.
    Vicdan, K.
    HUMAN REPRODUCTION, 2007, 22 : I83 - I83
  • [3] Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study
    Isik, A. Z.
    Caglar, G. S.
    Sozen, E.
    Akarsu, C.
    Tuncay, G.
    Ozbicer, T.
    Vicdan, K.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (04) : 472 - 477
  • [4] Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles
    Tesarik, Jan
    Hazout, Andre
    Mendoza-Tesarik, Raquel
    Mendoza, Nicolas
    Mendoza, Carmen
    HUMAN REPRODUCTION, 2006, 21 (10) : 2572 - 2579
  • [5] GnRH agonist administration in the luteal phase does not increase clinical pregnancy or implantation rates following ICSI-ET in GnRH agonist or antagonist treated ovarian stimulation cycles
    Ata, B.
    Yakin, K.
    Balaban, B.
    Urman, B.
    FERTILITY AND STERILITY, 2007, 88 : S163 - S163
  • [6] Ovarian hyperresponse to luteal phase GnRH-agonist administration
    Marion Depenbusch
    Klaus Diedrich
    Georg Griesinger
    Archives of Gynecology and Obstetrics, 2010, 281 : 1071 - 1072
  • [7] Ovarian hyperresponse to luteal phase GnRH-agonist administration
    Depenbusch, Marion
    Diedrich, Klaus
    Griesinger, Georg
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 281 (06) : 1071 - 1072
  • [8] Comparison of the standard GnRH antagonist protocol and the luteal phase estradiol/GnRH antagonist priming protocol in poor ovarian responders
    Mutlu, Mehmet Firat
    Mutlu, Ilknur
    Erdem, Mehmet
    Guler, Ismail
    Erdem, Ahmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (02) : 470 - 475
  • [9] GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study
    Ata, B.
    Yakin, K.
    Balaban, B.
    Urman, B.
    HUMAN REPRODUCTION, 2008, 23 (03) : 668 - 673
  • [10] Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation
    van Hooren, HG
    HUMAN REPRODUCTION, 2001, 16 (04) : 644 - 651
12345